EHS
EHS

New patent for NOVO drug WEGOVY – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug WEGOVY


Annual Drug Patent Expirations for WEGOVY

Wegovy is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug.

Drug patent litigation for WEGOVY.

This drug has seventy-five patent family members in thirty-two countries.

The generic ingredient in WEGOVY is semaglutide. Two suppliers are listed for this compound. Additional details are available on the semaglutide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug WEGOVY



Source link

EHS
Back to top button